PHARMACY

Perrigo, Ther-Rx announce availability of Gynazole-1

BY Alaric DeArment

ST. LOUIS — Perrigo and a subsidiary of K-V Pharmaceutical Co. have launched a new drug for yeast infections in women, the two companies said.

Perrigo and Ther-Rx Corp. announced the availability of Gynazole-1 (butoconazole nitrate vaginal cream) in the 2% strength for treating yeast infections in nonpregnant women.

Ther-Rx has a partnership with Perrigo to manufacture the drug.

"We are pleased to be able to once again offer Gynazole-1 to prescribing healthcare providers and to patients in need of therapy," K-V CEO and Ther-Rx president Greg Divis said. "The availability of Gynazole-1 represents a positive step forward for the company as we continue to provide quality, patient-friendly products to support the health of women across the stages of their lives."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

M.LANDIE says:
May-27-2013 05:52 am

Nicely written information in this post, I prefer to read this kind of stuff. The quality of content is fine and the conclusion is fine. Web Directory Engine

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

It’s official: Watson changes name to Actavis

BY Alaric DeArment

PARSIPPANY, N.J. — Watson Pharmaceuticals has formally changed its name to Actavis and changed its New York Stock Exchange ticker symbol to ACT, the company said Thursday.

The generic drug maker, now the world’s third largest, announced its plan to change the name last year after it acquired Actavis. The combined company expects combined 2012 sales to exceed $8 billion.

"Today marks an historic day for Actavis and a milestone in our evolution into a global pharmaceutical leader," Actavis president and CEO Paul Bisaro said. "While we have been operating as one company since last year, today we unite all of our 17,000 employees under a single name, trademarked and protected around the world."

The company has started a multi-year rebranding campaign in which it will change its website, factories, operations and commercial presence around the world and plans to ring the closing bell Thursday at the New York Stock Exchange.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Pharmacy retailers, one PBM dominated prescription drug revenues last year, study finds

BY Alaric DeArment

PHILADELPHIA — Five pharmacies dominated prescription drug dispensing revenues in the United States last year, according to a new study.

The proprietary study, by the Drug Channels Institute, found that pharmacy retailers CVS Caremark, Walgreens, Rite Aid, Walmart and pharmacy benefit manager Express Scripts accounted for 63% of all prescription drug revenues in the $276.5 billion U.S. pharmacy industry in 2012.

"Next year, these companies will benefit from healthcare reform’s implementation, which will sharply increase U.S. spending on prescription drugs," Drug Channels Institute CEO Adam Fein said.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?